[go: up one dir, main page]

AU2002218283A1 - Diagnosis of diseases associated with cdk4 by determining the methyl delivery state of cdk4 - Google Patents

Diagnosis of diseases associated with cdk4 by determining the methyl delivery state of cdk4

Info

Publication number
AU2002218283A1
AU2002218283A1 AU2002218283A AU1828302A AU2002218283A1 AU 2002218283 A1 AU2002218283 A1 AU 2002218283A1 AU 2002218283 A AU2002218283 A AU 2002218283A AU 1828302 A AU1828302 A AU 1828302A AU 2002218283 A1 AU2002218283 A1 AU 2002218283A1
Authority
AU
Australia
Prior art keywords
cdk4
diagnosis
methyl
determining
diseases associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218283A
Other languages
English (en)
Inventor
Kurt Berlin
Alexander Olek
Christian Piepenbrock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics AG filed Critical Epigenomics AG
Publication of AU2002218283A1 publication Critical patent/AU2002218283A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002218283A 2000-11-06 2001-11-06 Diagnosis of diseases associated with cdk4 by determining the methyl delivery state of cdk4 Abandoned AU2002218283A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10054974.8 2000-11-06
DE10054974A DE10054974A1 (de) 2000-11-06 2000-11-06 Diagnose von mit Cdk4 assoziierten Krankheiten
PCT/EP2001/012827 WO2002036814A2 (de) 2000-11-06 2001-11-06 Diagnose von mit cdk4 assoziierten krankheiten durch bestimmung des methylierungszustandes des cdk4

Publications (1)

Publication Number Publication Date
AU2002218283A1 true AU2002218283A1 (en) 2002-05-15

Family

ID=7662312

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218283A Abandoned AU2002218283A1 (en) 2000-11-06 2001-11-06 Diagnosis of diseases associated with cdk4 by determining the methyl delivery state of cdk4

Country Status (5)

Country Link
US (1) US20040072198A1 (de)
EP (1) EP1332228A2 (de)
AU (1) AU2002218283A1 (de)
DE (1) DE10054974A1 (de)
WO (1) WO2002036814A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001254794A1 (en) 2000-04-06 2001-10-23 Epigenomics Ag Diagnosis of diseases associated with dna adducts
WO2002077895A2 (en) * 2001-03-26 2002-10-03 Epigenomics Ag Method for epigenetic feature selection
DE10128508A1 (de) 2001-06-14 2003-02-06 Epigenomics Ag Verfahren und Nukleinsäuren für die Differenzierung von Prostata-Tumoren
DE10255104A1 (de) * 2002-08-27 2004-03-11 Epigenomics Ag Verfahren und Nukleinsäuren für die Analyse von proliferativen Erkrankungen von Brustzellen
DE10245779A1 (de) * 2002-10-01 2004-04-29 Epigenomics Ag Verfahren und Nukleinsäuren für die verbesserte Behandlung von proliferativen Erkrankungen von Brustzellen
US7932027B2 (en) 2005-02-16 2011-04-26 Epigenomics Ag Method for determining the methylation pattern of a polynucleic acid
EP1693468A1 (de) 2005-02-16 2006-08-23 Epigenomics AG Verfahren zur Bestimmung des Methylierungsmusters einer Polynukleinsäure
EP2481810A1 (de) 2005-04-15 2012-08-01 Epigenomics AG Verfahren zur Bereitstellung von DNA-Fragmenten, die von einer dezentralen Probe abgeleitet sind
DE102014108935B4 (de) 2013-09-06 2016-09-08 Westfalia Presstechnik Gmbh & Co. Kg Abdeckung für eine Bremse oder einen Bereich einer Bremse oder ein Rad eines Fahrzeuges, insbesondere Bremsabdeckblech
DE102014112858A1 (de) 2013-09-06 2015-03-12 Westfalia Presstechnik Gmbh & Co. Kg Flächenelement, insbesondere für ein Kraftfahrzeug
DE202014104211U1 (de) 2014-09-06 2015-12-09 Westfalia Presstechnik Gmbh & Co. Kg Flächenelement, insbesondere für ein Kraftfahrzeug

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962020A (en) * 1988-07-12 1990-10-09 President And Fellows Of Harvard College DNA sequencing
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5652099A (en) * 1992-02-12 1997-07-29 Conrad; Michael J. Probes comprising fluorescent nucleosides and uses thereof
US5821234A (en) * 1992-09-10 1998-10-13 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of proliferation of vascular smooth muscle cell
US5869462A (en) * 1992-09-10 1999-02-09 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of proliferation of vascular smooth muscle cell
WO1999027087A1 (en) * 1997-11-21 1999-06-03 Hybridon, Inc. Antisense oligonucleotides specific for cdk4
DE19754482A1 (de) * 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
JP2001526381A (ja) * 1997-12-05 2001-12-18 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ マトリックス補助レーザー脱着／イオン化質量分光分析による核酸の同定方法
WO1999064627A2 (en) * 1998-06-06 1999-12-16 Genostic Pharma Limited Probes used for genetic profiling
GB2339200B (en) * 1998-06-06 2001-09-12 Genostic Pharma Ltd Genostics
JP2002530436A (ja) * 1998-11-25 2002-09-17 ジェネティカ インコーポレイテッド 増殖能を増強しかつ複製老化を防止する方法及び試薬
DE19905082C1 (de) * 1999-01-29 2000-05-18 Epigenomics Gmbh Verfahren zur Identifikation von Cytosin-Methylierungsmustern in genomischen DNA-Proben
US20040029123A1 (en) * 2000-03-15 2004-02-12 Alexander Olek Diagnosis of diseases associated with the cell cycle
WO2002002807A2 (en) * 2000-06-30 2002-01-10 Epigenomics Ag Diagnosis of diseases associated with cell signalling
DE10128508A1 (de) * 2001-06-14 2003-02-06 Epigenomics Ag Verfahren und Nukleinsäuren für die Differenzierung von Prostata-Tumoren
JP2005516269A (ja) * 2001-07-02 2005-06-02 エピゲノミクス アーゲー エピジェネティックに基づく複合表現型の予測のための分散システム

Also Published As

Publication number Publication date
WO2002036814A2 (de) 2002-05-10
EP1332228A2 (de) 2003-08-06
US20040072198A1 (en) 2004-04-15
DE10054974A1 (de) 2002-06-06
WO2002036814A3 (de) 2003-04-10

Similar Documents

Publication Publication Date Title
AU2001289617A1 (en) Diagnosis of diseases associated with signal transduction
AU2003267091A1 (en) Optical coherence tomography probe
MXPA03002814A (es) Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
AUPR005600A0 (en) Diagnostic assay
AU6405300A (en) Chronic disease monitor
AU2002318759A1 (en) Remedies for diseases with bone mass loss having EP4 agonists as the active ingredient
AU2001282962A1 (en) Administering incentive award program
AU2002341963A1 (en) Flushable commode liner
AU2753000A (en) Mountable transducer assembly with removable sleeve
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
AU2001274922A1 (en) Internal cardiac output monitor
AU2002218283A1 (en) Diagnosis of diseases associated with cdk4 by determining the methyl delivery state of cdk4
WO2004105773A3 (en) Use of s1p
AU2001277653A1 (en) Diagnosis of known genetic parameters within the MHC
AU2002245754A1 (en) Fluid dispenser with fluid weight monitor
AU7408301A (en) Novel target genes for diseases of the heart
IT1318514B1 (it) Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
AU2002210438A1 (en) Diagnosis of diseases which are associated with cd24
AU6783900A (en) Methods for noninvasive analyte sensing
AU2001269420A1 (en) Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity
AU2001249144A1 (en) Novel cyclopentene derivatives useful as antagonists of the motilin receptor
AU3382001A (en) Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
AU2001228863A1 (en) Remedies for ophthalmic diseases
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases